Company / Operating Cash Flow
Disc Medicine, Inc. Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$180.4M
FY2025
5-year range
-$180.4M / -$27.5M
FY2021-FY2025
Trend
-92.1%
vs FY2024
Sector context
#165 of 216
Health Care
What the data says
Disc Medicine, Inc.'s operating cash flow of -$180M is lower than 76% of companies in the Health Care sector (FY2025). Operating Cash Flow has declined for 4 consecutive years, from -$28M in FY2021 to -$180M in FY2025.
Based on SEC 10-K filings.
-$180M in FY2025.
Declined from -$73M to -$180M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 216This company -$180.4M Sector average $659.0M
▼
-127.4% below sector average
Key checks
Key Insights
- Disc Medicine, Inc.'s operating cash flow has declined for 4 consecutive years.
- In FY2025, operating cash flow decreased 92.1% year-over-year.
- Ranks #165 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$180.4M | -92.1% |
| FY2024 | -$93.9M | -27.9% |
| FY2023 | -$73.5M | -73.9% |
| FY2022 | -$42.3M | -53.5% |
| FY2021 | -$27.5M | +15.8% |
| FY2020 | -$32.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026